From MarketBeat:

Schmidt P J Investment Management Inc. increased its position in shares of Stryker Co. (SYK) by 30.4% during the 3rd quarter to 19,678 shares, worth $5,282,000. Another institutional investor, Zions Bancorporation N.A., grew its holdings in Stryker by 9.2% during the 1st quarter with 3,140 shares of the medical technology company’s stock worth $839,000. Truist Financial boosted Stryker’s price target from $300.00 to $320.00.

A number of analysts have recently issued reports on Stryker, including Truist Financial’s upgrade from $300.00 to $320.00 and a “hold” rating from UBS Group, with a $297.00 target. StockNews.com recommends a “buy” rating for Stryker, with an average rating of “Moderate Buy” and a consensus price target of $315.90.

Director Srikant M. Datar sold 2,000 shares of Stryker’s stock, including 500 shares at an average price of $291.92, and 750 shares at an average price of $287.57. The company’s insiders sold 58,306 shares of company stock over the last 90 days, and they own 5.90% of the company’s stock.

Stryker Co. has a 1-year low of $241.68 and a 1-year high of $306.93. The company has a market capitalization of $113.76 billion, a price-to-earnings ratio of 44.43, and a beta of 0.94. The firm last released its earnings results on Thursday, November 2nd, reporting $2.46 earnings per share for the quarter. The company had revenue of $4.90 billion during the quarter, compared to the consensus estimate of $4.87 billion. Stryker is expected to post 10.41 earnings per share for the current year.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine, and provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries.

Before you consider Stryker, you’ll want to hear this. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now.



Read more: Schmidt P J Investment Management Inc. Increases Stock Position in Stryker Co. (NYSE:SYK)